Tirzepatide Injections
Leading IT / Technology Services of mounjaro 5mg injection 0.5 ml, mounjaro 5 mg kwikpen 2.4ml tirzepatide injection, mounjaro 7.5 mg kwikpen 2.4ml tirzepatide injection, mounjaro 2.5mg injection 0.5 ml, mounjaro 12.5 mg kwikpen 2.4ml tirzepatide injection and mounjaro 10 mg kwikpen 2.4ml tirzepatide injection from Nagpur.
Mounjaro 5mg Injection 0.5 ml
Approx. Price: Rs 4,100 / VialGet Latest Price Product Details:
| Strength | 5 mg/0.5 ml |
| Brand | Mounjaro |
| Application | Type 2 Diabetes |
| Delivery Form | Vial |
| Pack Size | Vial |
| Shelf Life | 24 months |
| Composition | Tirzepatide 5mg |
| Country Of Origin | India |
| Usage | Human Use |
Mounjaro 5mg Solution for Injection 0.5 ml is used to treat type II diabetes. It is also used to treat obesity. It contains Tirzepatide, which works by increasing insulin levels, slowing gastric emptying. This medicine may cause side effects such as vomiting, nausea, abdominal pain, diarrhoea, headache and allergic reactions. Each KwikPen delivers four doses, offering convenient once-weekly administration for a full month's treatment.
Mounjaro 5 mg KwikPen 2.4ml Tirzepatide Injection
Approx. Price: Rs 15,200 / BoxGet Latest Price Product Details:
| Strength | 5 mg/0.6 ml |
| Brand | Mounjaro |
| Application | Weight Management, Type 2 Diabetes |
| Delivery Form | Prefilled Pen |
| Pack Size | 1 multidose kwikpen |
| Storage Temperature | 2–8°C (Refrigerated) |
| Shelf Life | 24 months |
| Prescription Type | Rx Only |
| Composition | Tirzepatide 5mg |
| Country Of Origin | India |
| Usage | Human Use |
Mounjaro 5 mg KwikPen (Tirzepatide Injection) is used for the management of type 2 diabetes mellitus in adults. Tirzepatide is a dual GIP and GLP-1 receptor agonist, which helps regulate blood sugar by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. It not only improves glycemic control but also supports weight reduction, making it beneficial for patients struggling with obesity alongside diabetes.
Mounjaro 7.5 mg KwikPen 2.4ml Tirzepatide Injection
Approx. Price: Rs 19,500 / BoxGet Latest Price Product Details:
| Strength | 7.5 mg/0.5 ml |
| Brand | Mounjaro |
| Application | Type 2 Diabetes |
| Delivery Form | Prefilled Pen |
| Pack Size | 1 multidose kwikpen |
| Shelf Life | 24 months |
| Prescription Type | Rx Only |
| Composition | Tirzepatide 7.5mg |
| Country Of Origin | India |
| Usage | Human Use |
Mounjaro 7.5 mg KwikPen (Tirzepatide Injection) is used for the management of type 2 diabetes mellitus in adults. Tirzepatide is a dual GIP and GLP-1 receptor agonist, which helps regulate blood sugar by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. It not only improves glycemic control but also supports weight reduction, making it beneficial for patients struggling with obesity alongside diabetes.
Mounjaro 2.5mg Injection 0.5 ml
Approx. Price: Rs 3,800 / VialGet Latest Price Product Details:
| Strength | 2.5 mg/0.5 ml |
| Brand | Mounjaro |
| Application | Weight Management, Type 2 Diabetes |
| Delivery Form | Vial |
| Pack Size | 2.5mg vial |
| Storage Temperature | 2–8°C |
| Shelf Life | 24 months |
| Prescription Type | Rx Only |
| Composition | Tirzepatide 2.5mg |
| Country Of Origin | India |
| Usage | Human Use |
Mounjaro 2.5mg Solution for Injection 0.5 ml is used to treat type II diabetes. It is also used to treat obesity. It contains Tirzepatide, which works by increasing insulin levels, slowing gastric emptying. This medicine may cause side effects such as vomiting, nausea, abdominal pain, diarrhoea, headache and allergic reactions. Each KwikPen delivers four doses, offering convenient once-weekly administration for a full month's treatment.
Mounjaro 12.5 mg KwikPen 2.4ml Tirzepatide Injection
Approx. Price: Rs 23,800 / BoxGet Latest Price Product Details:
| Strength | 12.5mg/0.6ml |
| Brand | Mounjaro |
| Application | Type 2 Diabetes, Weight Management |
| Delivery Form | Prefilled Pen |
| Pack Size | 1 multidose kwikpen |
| Storage Temperature | 2–8°C |
| Shelf Life | 24 months |
| Prescription Type | Rx Only |
| Composition | Tirzepatide 12.5mg |
| Country Of Origin | India |
| Usage | Human Use |
Mounjaro 12.5 mg KwikPen (Tirzepatide Injection) is used for the management of type 2 diabetes mellitus in adults. Tirzepatide is a dual GIP and GLP-1 receptor agonist, which helps regulate blood sugar by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. It not only improves glycemic control but also supports weight reduction, making it beneficial for patients struggling with obesity alongside diabetes.
Mounjaro 10 mg KwikPen 2.4ml Tirzepatide Injection
Approx. Price: Rs 19,500 / BoxGet Latest Price Product Details:
| Strength | 10mg/0.6ml |
| Brand | Mounjaro |
| Application | Type 2 Diabetes |
| Delivery Form | Prefilled Pen |
| Pack Size | 1 multidose kwikpen |
| Storage Temperature | 2–8°C |
| Shelf Life | 24 months |
| Prescription Type | Rx Only |
| Composition | Tirzepatide 10mg |
| Country Of Origin | India |
| Usage | Human Use |
Mounjaro 10 mg KwikPen (Tirzepatide Injection) is used for the management of type 2 diabetes mellitus in adults. Tirzepatide is a dual GIP and GLP-1 receptor agonist, which helps regulate blood sugar by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. It not only improves glycemic control but also supports weight reduction, making it beneficial for patients struggling with obesity alongside diabetes.
Mounjaro 15 Mg KwikPen Tirzepatide Injection
Approx. Price: Rs 25,000 / BoxGet Latest Price Product Details:
| Brand | Mounjaro |
| Strength | 15 mg/0.6 ml |
| Pack Size | 1 prefilled pen |
| Delivery Form | Prefilled Pen |
| Prescription Type | Rx Only |
| Shelf Life | 18 months |
| Usage | Human Use |
| Country Of Origin | India |
Mounjaro 15 mg KwikPen (Tirzepatide Injection) is used for the management of type 2 diabetes mellitus in adults. Tirzepatide is a dual GIP and GLP-1 receptor agonist, which helps regulate blood sugar by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. It not only improves glycemic control but also supports weight reduction, making it beneficial for patients struggling with obesity alongside diabetes.